✦ LIBER ✦

Cystic fibrosis related diabetes

✍ Scribed by Alexander, S ;Bridges, N

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 488 KB
Volume: 27
Category: Article
ISSN: 1357-8170
DOI: 10.1002/pdi.1481

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Cystic fibrosis related diabetes is the most common co‐morbidity in cystic fibrosis. Insulin deficiency is the key factor in the development of cystic fibrosis related diabetes, which is associated with worse pulmonary and nutritional morbidity and increased mortality.

The oral glucose tolerance test remains standard for screening, but continuous glucose monitoring systems are increasingly used to help with screening and management.

Insulin is the only treatment with evidence of benefit. The timing of insulin treatment, and the level of glycaemia for which to aim, are areas which need further research.

📜 SIMILAR VOLUMES

Vitamin D deficiency as a risk factor fo

Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian Cystic Fibrosis Nutritional Study

✍ T. Pincikova; K. Nilsson; I. E. Moen; G. Fluge; A. Hollsing; P. K. Knudsen; A. L 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 154 KB

Cystic Fibrosis Related Diabetes (CFRD)—

Cystic Fibrosis Related Diabetes (CFRD)—The End Stage of Progressive Insulin Deficiency

✍ Shihab Hameed; Adam Jaffé; Charles F. Verge 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

## Abstract In cystic fibrosis, gradual pancreatic destruction causes progressive insulin deficiency, culminating in cystic fibrosis related diabetes (CFRD). As a consequence of insulin deficiency, elevated glucose levels can be detected (well before the diagnosis of CFRD), by continuous ambulatory

Cystic fibrosis-related diabetes is asso

Cystic fibrosis-related diabetes is associated with HLADQB1alleles encoding Asp-57−molecules

✍ Mary Carrington; Leslie J. Krueger; Douglas S. Holsclaw; Michael C. Iannuzzi; Mi 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 553 KB

Insulin therapy in patients with cystic

Insulin therapy in patients with cystic fibrosis related diabetes mellitus: benefit, timing of initiation and hypoglycaemia

✍ Drummond, RS ;Ross, E ;Bicknell, S ;Small, M ;Jones, GC 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 709 KB

## Abstract Pancreatic endocrine dysfunction in patients with cystic fibrosis heralds declining pulmonary function and a six‐fold rise in mortality. Insulin therapy increases weight and reduces decline in lung function. Optimal timing of initiation remains contentious but early intervention may max

Pseudomonasin cystic fibrosis

✍ B. Gordts 📂 Article 📅 1984 🏛 Springer Netherlands 🌐 English ⚖ 143 KB

Cystic fibrosis associated islet changes

Cystic fibrosis associated islet changes may provide a basis for diabetes

✍ L�hr, M. ;Goertchen, P. ;Nizze, H. ;Gould, N. S. ;Gould, V. E. ;Oberholzer, M. ; 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 816 KB